Core Viewpoint - Yangshan Medical has successfully completed a multi-million RMB pre-A round financing, indicating strong investor confidence in the company's innovative solutions for oral and maxillofacial surgery [2][6]. Group 1: Company Overview - Yangshan Medical focuses on providing full-process solutions for oral and maxillofacial surgeries using robotics, artificial intelligence, and innovative passive medical devices [6]. - The company has developed China's first surgery robot utilizing new navigation technology, which will be applied in oral implant surgeries, showcasing advantages such as zero registration, unobstructed operation, interference resistance, rapid surgery, short learning curve, and miniaturization [6]. Group 2: Product Innovations - The Dental Implant Distractor (DID) is a globally pioneering product that revolutionizes traditional vascularized fibula grafting techniques for mandibular reconstruction, having won the National Science and Technology Progress Award in 2019 and entering the special review process for innovative medical devices in 2025 [6][7]. Group 3: Market Potential and Investment Insights - The medical surgical robot sector is experiencing a dual benefit of technological implementation and demand release, with Yangshan Medical establishing a strong barrier in core navigation technology and product adaptation for oral scenarios [7]. - Investors express optimism about the company's solid technical foundation and clear commercialization path, anticipating that this investment will accelerate market penetration and promote digital transformation in the oral industry [7][8]. - The shift towards precision and intelligence in oral implant procedures is expected to create a market worth hundreds of billions, reshaping the industry ecosystem [7].